drugset / Trial / NCT00143819
Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis
Phase 2
Terminated
13 enrolled
University of Medicine and Dentistry of New Jersey
AVVAA World Healthcare Products, Inc. · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the efficacy of Neuroskin Forte in relieving the symptoms of dry skin in adults with psoriasis or eczema.
Timeline
- Start
- 2005-09
- Primary completion
- 2010-02
- Completion
- 2010-02
Outcome
Outcome not reported
Stopped (Enrollment): “Low enrollment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neuroskin Forte | Unknown | — | Topical |